Effects of β-aescin on apoptosis induced by transient focal cerebral ischemia in rats

Acta Pharmacologica Sinica

Volumn 25, Issue 10, 2004, Pages 1267-1275

  Hu, Xia Min ^a   Zhang, Yan ^b   Zeng, Fan Dian ^a  

^a Institute of Clinical Pharmacology   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; Bcl 2 genes; Beta aescin; Brain ischemia; Caspases; Cytochromes c

Indexed keywords

BETA ESCIN; CASPASE 3; CYTOCHROME C; EOSIN; HEMATOXYLIN; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOSOL; DRUG EFFECT; DRUG EFFICACY; DRUG STRUCTURE; ENZYME RELEASE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; RAT; RAT STRAIN; REPERFUSION INJURY; TRANSIENT ISCHEMIC ATTACK; UPREGULATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BRAIN ISCHEMIA; CASPASE 3; CASPASES; CEREBRAL CORTEX; CYTOCHROMES C; ESCIN; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MITOCHONDRIA; NEUROPROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 5444227636     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Guillaume M, Padioleau F. Veintonic effect, vascular protection, anti-inflammatory and free radical scavenging properties of horse chestnut extract. Arzneim-Forsch/Drug Res 1994; 44: 25-35.
2. Sirtori CR. Aescin: pharmcology, pharmacokinetics and therapeutic profile. Pharmacol Res 2001; 44: 183-93.
3. Shen YW, Zhu ZF, Zhang JC. Observation on the effect of β-sodium aescin intracerebral hemorrhage. Hebei Med 1999; 5: 9-11.
4. Dienel GA, Pulsinelli WA, Duffy TE. Regional protein synthesis in rat brain following acute hemispheric ischemia. J Neurochem 1980; 35: 1216-26.
5. Liu PK. Ischemia-reperfusion-related repair deficit after oxidative stress: implications of faulty transcripts in neuronal sensitivity after brain injury. J Biomed Sci 2003; 10: 4-13.
6. Kirsch DG, Doseff A, Chau BN, Lim DS, de Souza-Pinto NC, Hansford R, et al. Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c. J Biol Chem 1999; 274: 21155-61.
7. Ji XY, Tan BKH, Zhu YZ. Salvia miltiorrhiza and ischemic diseases. Acta Pharmacol Sin 2000; 21: 1089-94.
8. Ohigashi T, Ueno M, Nonaka S, Nakanoma T, Furukawa Y, Deguchi N, et al. Tyrosine kinase inhibitors reduce bcl-2 expression and induce apoptosis in androgen-dependent cells. Am J Physiol Cell Physiol 2000; 278: C66-72.
9. Fisher M, Bogousslavsky J. Further evaluation toward effective therapy for acute ischemic stroke. J Am Med Assoc 1998; 279: 1298-303.
10. Fujimura M, Morita-Fujimura Y, Murakami K, Kawase M, Chan PH. Cytosolic redistribution of cytochrome c after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1998; 18: 1239-47.
11. Zhang BF, Peng FF, Zhang JZh, Wu DC. Staurosporine induces apoptosis in NG108-15 cells. Acta Pharmacol Sin 2003; 24: 663-9.
12. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science (Wash DC) 1997; 275: 1131-6.
13. Shimizu S, Tsujimoto Y. Proapoptotic BH3-only Bcl-2 family members induce cytochrome c release, but not mitochondrial membrane potential loss, and do not directly modulate voltage-dependent anion channel activity. Proc Natl Acad Sci USA 2000; 97: 77-82.
14. Gross A, Yin XM, Wang K, Wei MC, Jockel J, Milliman C, et al. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem 1999; 274: 1156-63.
15. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniotomy in rats. Stroke 1989; 20: 84-91.
16. Bedenson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurological examination. Stroke 1986; 17: 472-6
17. Guang Q, Wang XL. Effects of chiral 3-n-butylphthalide on apoptosis induced by transient focal cerebral ischemia in rats. Acta Pharmacol Sin 2003; 24: 796-804.
18. Li Y, Chopp M, Jiang N, Yao F, Zaloga C. Temporal profile of in situ DNA fragmentation after transient middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 1995; 15: 389-97.
19. Kroemer G. The mitochondrion as an integrator/coordinator of cell death pathways. Cell Death Differ 1998; 5: 547.
20. Cai J, Jones DP. Superoxide in apoptosis. Mitochondrial generation triggered by cytrochrome loss. J Biol Chem 1996; 273: 11401-4.
21. Oltvai Z, Milliman C, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-19.
22. Yang G, Chan PH, Chen J, Carlson E, Chen SF, Weinstein P, et al. Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke 1994; 25: 165-70.
23. Kao H, Takasawa R, Fukuda K, Shiokawa D, Sadanaga-Akiyoshi F, Ibayashi S, et al. DNA fragmentation in ischemic core and penumbra in focal cerebral ischemia in rats. Mol Brain Res 2001; 91: 112-8.
24. Bredesen DE. Neural apoptosis. Ann Neurol 1995; 38: 839-51.
25. Savitz SI, Rosenbaum DM. Apoptosis in neurological disease. Neurosurgery 1998; 42: 555-72.
26. Schulz JB, Weller M, Moskowitz MA. Caspases as treatment targets in stroke and neurodegenerative disease. Ann Neurol 1999; 45: 421-9.
27. Martinou JC. Apoptosis. Key to the mitochondrial gate. Nature 1999; 399: 411-2.
28. Wiessner C, Allegrini PR, Rupalla K, Sauer D, Oltersdorf T, McGregor AL, et al. Neuron-specific transgene expression of Bcl-XL but not Bcl-2 genes reduced lesion size after permanent middle cerebral artery occlusion in mice. Neurosci Lett 1999; 268: 119-22.